Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Thiel, U; Wawer, A; Wolf, P; Badoglio, M; Santucci, A; Klingebiel, T; Basu, O; Borkhardt, A; Laws, HJ; Kodera, Y; Yoshimi, A; Peters, C; Ladenstein, R; Pession, A; Prete, A; Urban, EC; Schwinger, W; Bordigoni, P; Salmon, A; Diaz, MA; Afanasyev, B; Lisukov, I; Morozova, E; Toren, A; Bielorai, B; Korsakas, J; Fagioli, F; Caselli, D; Ehninger, G; Gruhn, B; Dirksen, U; Abdel-Rahman, F; Aglietta, M; Mastrodicasa, E; Torrent, M; Corradini, P; Demeocq, F; Dini, G; Dreger, P; Eyrich, M; Gozdzik, J; Guilhot, F; Holler, E; Koscielniak, E; Messina, C; Nachbaur, D; Sabbatini, R; Oldani, E; Ottinger, H; Ozsahin, H; Schots, R; Siena, S; Stein, J; Sufliarska, S; Unal, A; Ussowicz, M; Schneider, P; Woessmann, W; Jürgens, H; Bregni, M; Burdach, S; on behalf of the Solid Tumor Working Party (STWP) and the Pediatric Disease Working Party (PDWP) of the European Group for Blood and Marrow Transplantation (EBMT), the Asia Pacific Blood and Marrow Transplantation (APBMT), the Pediatric Registry for Stem Cell Transplantations (PRST); the MetaEICESS Study Group.
No improvement of survival with reduced- versus high-intensity conditioning for allogeneic stem cell transplants in Ewing tumor patients.
Ann Oncol. 2011; 22(7): 1614-1621.
Doi: 10.1093/annonc/mdq703
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
- Schwinger Wolfgang
- Urban Ernst-Christian
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Background: Outcomes of Ewing tumor (ET) patients treated with allogeneic stem cell transplantation (allo-SCT) were compared regarding the use of reduced-intensity conditioning (RIC) and high-intensity conditioning (HIC) regimens as well as human leukocyte antigen (HLA)-matched and HLA-mismatched grafts. Patients and methods: We retrospectively analyzed data of 87 ET patients from the European Group for Blood and Marrow Transplantation, Pediatric Registry for Stem Cell Transplantations, Asia Pacific Blood and Marrow Transplantation and MetaEICESS registries treated with allo-SCT. Fifty patients received RIC (group A) and 37 patients received HIC (group B). Twenty-four patients received HLA-mismatched grafts and 63 received HLA-matched grafts. Results: Median overall survival was 7.9 months [+/- 1.24, 95% confidence interval (CI) 5.44-10.31] for group A and 4.4 months (+/- 1.06, 95% CI 2.29-6.43) for group B patients (P = 1.3). Death of complications (DOC) occurred in 4 of 50 (0.08) and death of disease (DOD) in 33 of 50 (0.66) group A and in 16 of 37 (0.43) and 17 of 37 (0.46) group B patients, respectively. DOC incidence was decreased (P < 0.01) and DOD/relapse increased (P < 0.01) in group A compared with group B. HLA mismatch was not generally associated with graft-versus-Ewing tumor effect (GvETE). Conclusions: There was no improvement of survival with RIC compared with HIC due to increased DOD/relapse incidence after RIC despite less DOC incidence. This implicates general absence of a clinically relevant GvETE with current protocols.
- Find related publications in this database (using NLM MeSH Indexing)
- Adolescent -
- Adult -
- Bone Neoplasms - mortality Bone Neoplasms - therapy
- Child -
- Child, Preschool -
- Female -
- Follow-Up Studies -
- Graft vs Host Disease - therapy
- Humans -
- Male -
- Middle Aged -
- Retrospective Studies -
- Sarcoma, Ewing - mortality Sarcoma, Ewing - therapy
- Stem Cell Transplantation -
- Survival Rate -
- Transplantation Conditioning -
- Transplantation, Homologous -
- Treatment Outcome -
- Young Adult -
- Find related publications in this database (Keywords)
- advanced-stage Ewing tumor
- allogeneic stem cell transplantation
- graft versus tumor effect
- haploidentical stem cell transplantation
- reduced
- high-intensity conditioning chemotherapy